XML 27 R14.htm IDEA: XBRL DOCUMENT v3.4.0.3
Financial Instruments Owned And Financial Instruments Sold, But Not Yet Purchased
12 Months Ended
Dec. 31, 2015
Trading Securities Balance Sheet Reported Amounts [Abstract]  
Financial Instruments Owned And Financial Instruments Sold, But Not Yet Purchased

NOTE 7 – Financial Instruments Owned and Financial Instruments Sold, But Not Yet Purchased

The components of financial instruments owned and financial instruments sold, but not yet purchased, at December 31, 2015 and 2014 are as follows (in thousands):

 

 

 

December 31,

 

 

 

2015

 

 

2014

 

Financial instruments owned:

 

 

 

 

 

 

 

 

U.S. government securities

 

$

45,167

 

 

$

58,992

 

U.S. government agency securities

 

 

116,949

 

 

 

101,439

 

Mortgage-backed securities:

 

 

 

 

 

 

 

 

Agency

 

 

205,473

 

 

 

159,057

 

Non-agency

 

 

33,319

 

 

 

13,366

 

Corporate securities:

 

 

 

 

 

 

 

 

Fixed income securities

 

 

203,910

 

 

 

245,909

 

Equity securities

 

 

31,642

 

 

 

77,548

 

State and municipal securities

 

 

112,983

 

 

 

130,544

 

 

 

$

749,443

 

 

$

786,855

 

Financial instruments sold, but not yet purchased:

 

 

 

 

 

 

 

 

U.S. government securities

 

$

186,030

 

 

$

146,592

 

U.S. government agency securities

 

 

 

 

 

10,029

 

Mortgage-backed securities:

 

 

 

 

 

 

 

 

Agency

 

 

50,830

 

 

 

28,067

 

Non-agency

 

 

 

 

 

4,556

 

Corporate securities:

 

 

 

 

 

 

 

 

Fixed income securities

 

 

255,700

 

 

 

293,008

 

Equity securities

 

 

29,184

 

 

 

105,013

 

 

 

$

521,744

 

 

$

587,265

 

 

At December 31, 2015 and 2014, financial instruments owned in the amount of $508.5 million and $425.1 million, respectively, were pledged as collateral for our repurchase agreements and short-term borrowings.

Financial instruments sold, but not yet purchased, represent obligations of our company to deliver the specified security at the contracted price, thereby creating a liability to purchase the security in the market at prevailing prices in future periods. We are obligated to acquire the securities sold short at prevailing market prices in future periods, which may exceed the amount reflected in the consolidated statements of financial condition.